Bend, OR, United States of America

Xiangming Wu

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Bionomics Inc.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Xiangming Wu. Retrieved from https://idiyas.com/inventor/xiangming-wu-176vgr7b

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Xiangming Wu: Innovator in Therapeutic Formulations

Introduction

Xiangming Wu is a notable inventor based in Bend, OR (US). He has made significant contributions to the field of therapeutic formulations, particularly in the treatment of central nervous system diseases. His innovative work focuses on the development of compounds that offer non-sedative anxiolytic effects.

Latest Patents

Xiangming Wu holds a patent for "Therapeutic formulations and uses thereof." This invention relates to formulations of compound (I) (BNC210), an allosteric modulator of the α7-nicotinic receptor. The patent specifically addresses solid dispersions, methods of manufacture, and therapeutic methods for treating diseases of the central nervous system. He has 1 patent to his name.

Career Highlights

Wu is currently associated with Bionomics Inc., where he continues to advance his research and development efforts. His work has the potential to impact the treatment landscape for various neurological conditions.

Collaborations

Some of his notable coworkers include Dharam Paul and Julia Crossman, who contribute to the collaborative environment at Bionomics Inc. Their combined expertise fosters innovation and progress in therapeutic research.

Conclusion

Xiangming Wu's contributions to therapeutic formulations highlight his role as an important inventor in the field. His work not only advances scientific understanding but also holds promise for improving patient outcomes in the treatment of central nervous system diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…